Cite
HARVARD Citation
Modjarrad, K. et al. (2019). Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. Lancet infectious diseases. 19 (9), pp. 1013-1022. [Online].